ALDH3B2 and cholangiocarcinoma: The results revealed that knockdown of ALDH3B2 promoted the expression of E-cadherin and inhibited the expression of N-cadherin and snail, indicating that ALDH3B2 may also promote the progression of cholangiocarcinoma by promoting EMT.